MicuRx Pharmaceuticals Company
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Employee Number:
11-50
Funding Status:
Late Stage Venture
Headquarters:
Hayward, California, United States
Technology:
Small Molecules
Estimated Revenue:
$10M to $50M
Founded Date:
2007
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech